221 related articles for article (PubMed ID: 23704824)
101. Downregulation of heparanase by RNA interference inhibits invasion and tumorigenesis of hepatocellular cancer cells in vitro and in vivo.
Xiong Z; Lü MH; Fan YH; Cao YL; Hu CJ; Wu YY; Wang SM; Luo G; Fang DC; Li C; Yang SM
Int J Oncol; 2012 May; 40(5):1601-9. PubMed ID: 22267022
[TBL] [Abstract][Full Text] [Related]
102. Expression of USP22 and Survivin is an indicator of malignant behavior in hepatocellular carcinoma.
Tang B; Liang X; Tang F; Zhang J; Zeng S; Jin S; Zhou L; Kudo Y; Qi G
Int J Oncol; 2015 Dec; 47(6):2208-16. PubMed ID: 26497847
[TBL] [Abstract][Full Text] [Related]
103. Nogo-C contributes to HCC tumorigenesis via suppressing cell growth and its interactome analysis with comparative proteomics research.
Liu X; Cui SJ; Zhu SJ; Geng DC; Yu L
Int J Clin Exp Pathol; 2014; 7(5):2044-55. PubMed ID: 24966913
[TBL] [Abstract][Full Text] [Related]
104. Downregulation of P-cadherin expression in hepatocellular carcinoma induces tumorigenicity.
Bauer R; Valletta D; Bauer K; Thasler WE; Hartmann A; Müller M; Reichert TE; Hellerbrand C
Int J Clin Exp Pathol; 2014; 7(9):6125-32. PubMed ID: 25337260
[TBL] [Abstract][Full Text] [Related]
105. Tumor-suppressive role of microfibrillar associated protein 4 and its clinical significance as prognostic factor and diagnostic biomarker in hepatocellular carcinoma.
Li J; Wang J; Liu Z; Guo H; Wei X; Wei Q; Zheng S; Xu X
J Cancer Res Ther; 2022 Dec; 18(7):1919-1925. PubMed ID: 36647950
[TBL] [Abstract][Full Text] [Related]
106. TO901317 inhibits the development of hepatocellular carcinoma by LXRα/Glut1 decreasing glycometabolism.
Xiong T; Li Z; Huang X; Lu K; Xie W; Zhou Z; Tu J
Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G598-G607. PubMed ID: 30817182
[TBL] [Abstract][Full Text] [Related]
107. Negative correlation of LIV-1 and E-cadherin expression in hepatocellular carcinoma cells.
Shen R; Xie F; Shen H; liu Q; Zheng T; Kou X; Wang D; Yang J
PLoS One; 2013; 8(2):e56542. PubMed ID: 23437163
[TBL] [Abstract][Full Text] [Related]
108. ISOC1 is a novel potential tumor suppressor in hepatocellular carcinoma.
Xiang J; Gao XQ; Chen XL; Lu YY
Neoplasma; 2022 Jan; 69(1):174-182. PubMed ID: 34846160
[TBL] [Abstract][Full Text] [Related]
109. The potential contributions of a Y-located protooncogene and its X homologue in sexual dimorphisms in hepatocellular carcinoma.
Kido T; Lo RC; Li Y; Lee J; Tabatabai ZL; Ng IO; Lau YF
Hum Pathol; 2014 Sep; 45(9):1847-58. PubMed ID: 25017435
[TBL] [Abstract][Full Text] [Related]
110. AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation.
Bian X; Shi D; Xing K; Zhou H; Lu L; Yu D; Wu W
Clin Transl Med; 2021 Mar; 11(3):e352. PubMed ID: 33783988
[TBL] [Abstract][Full Text] [Related]
111. Tryptophan Side-Chain Oxidase Enzyme Suppresses Hepatocellular Carcinoma Growth through Degradation of Tryptophan.
Ai Y; Wang B; Xiao S; Luo S; Wang Y
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830310
[TBL] [Abstract][Full Text] [Related]
112. Cytokeratin 8 is increased in hepatitis C virus cells and its ectopic expression induces apoptosis of SMMC7721 cells.
Sun MZ; Dang SS; Wang WJ; Jia XL; Zhai S; Zhang X; Li M; Li YP; Xun M
World J Gastroenterol; 2013 Oct; 19(37):6178-87. PubMed ID: 24115814
[TBL] [Abstract][Full Text] [Related]
113. Expressions of heparanase and upstream stimulatory factor in hepatocellular carcinoma.
Chen B; Chen XP; Wu MS; Cui W; Zhong M
Eur J Med Res; 2014 Aug; 19(1):45. PubMed ID: 25149140
[TBL] [Abstract][Full Text] [Related]
114. CDCA8 Facilitates Tumor Proliferation and Predicts a Poor Prognosis in Hepatocellular Carcinoma.
Cui Y; Jiang N
Appl Biochem Biotechnol; 2024 Mar; 196(3):1481-1492. PubMed ID: 37428386
[TBL] [Abstract][Full Text] [Related]
115. Cysteine-rich intestinal protein 1 enhances the progression of hepatocellular carcinoma via Ras signaling.
He HY; Hu L
Kaohsiung J Med Sci; 2022 Jan; 38(1):49-58. PubMed ID: 34585826
[TBL] [Abstract][Full Text] [Related]
116. SPC25 overexpression promotes tumor proliferation and is prognostic of poor survival in hepatocellular carcinoma.
Zhang B; Zhou Q; Xie Q; Lin X; Miao W; Wei Z; Zheng T; Pang Z; Liu H; Chen X
Aging (Albany NY); 2020 Dec; 13(2):2803-2821. PubMed ID: 33408271
[TBL] [Abstract][Full Text] [Related]
117. Expression of SGTA correlates with prognosis and tumor cell proliferation in human hepatocellular carcinoma.
Lu C; Liu G; Cui X; Zhang J; Wei L; Wang Y; Yang X; Liu Y; Cong X; Lv L; Ni R; Huang X
Pathol Oncol Res; 2014 Jan; 20(1):51-60. PubMed ID: 23839012
[TBL] [Abstract][Full Text] [Related]
118. [Roles of PIK3R1 gene in development of hepatocellular carcinoma].
Zheng YX; Zhang CW; Hui B; Ding BY; Ao L; Dong B; Zhou XM
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 43(5):559-65. PubMed ID: 25372641
[TBL] [Abstract][Full Text] [Related]
119. [Hepatitis B virus down-regulates the expression of inhibin and promotes the proliferation and survival of hepatocellular carcinoma cells].
Liu JY; Shao JY; Liu Y; Li H; Kong X; Zhao Y; Fan YM; Wu B; Zhao M
Zhonghua Gan Zang Bing Za Zhi; 2023 Mar; 31(3):288-292. PubMed ID: 37137855
[No Abstract] [Full Text] [Related]
120. Downregulating sCLU enhances the sensitivity of hepatocellular carcinoma cells to gemcitabine by activating the intrinsic apoptosis pathway.
Xiu P; Xu Z; Liu F; Li Z; Li T; Zou F; Sun X; Li J
Dig Dis Sci; 2014 Aug; 59(8):1798-809. PubMed ID: 24671452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
